Basic aspects of catechol-O-methyltransferase and the clinical applications of its inhibitors /
General Material Designation
[Book]
First Statement of Responsibility
editor, Erkki Nissinen
PROJECTED PUBLICATION DATE
Date
201012
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
xii, 323 pages :
Other Physical Details
illustrations ;
Dimensions
24 cm
SERIES
Series Title
International review of neurobiology ;
Volume Designation
v. 95
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references and index
CONTENTS NOTE
Text of Note
Cover; International Review of Neurobiology; Copyright; Contributors; Preface; Introductory Remarks: Catechol-O-Methyltransferase Inhibition -- An Innovative Approach To Enhance l-Dopa Therapy In Parkinson'S D; The Catechol-O-Methyltransferase Gene: Its Regulation and Polymorphisms; Distribution and Functions of Catechol-O-Methyltransferase Proteins: Do Recent Findings Change The Picture?; Catechol-O-Methyltransferase Enzyme: Cofactor S-Adenosyl-l-Methionine And Related Mechanisms; Biochemistry And Pharmacology Of Catechol-O-Methyltransferase Inhibitors
0
SUMMARY OR ABSTRACT
Text of Note
"Since its discovery in 1958, the Catechol-O-methyltransferase (COMT) enzyme has generated a lot of excitement, particularly so in more recent years with the discovery of clinically relevant COMT inhibitors in the late 1980's. While the volume of published research on the COMT enzyme and its inhibitors is substantial, there is no comprehensive, up-to-date source containing all the information available on basic COMT biochemistry and pharmacology, as well as critical review of results from clinical trials. This volume of International Review of Neurobiology summarizes what is currently known about COMT enzyme: its genomics, structure, function and biochemical properties; and presents up-to-date evaluation of the clinical use of COMT inhibitors as an adjunct to levodopa/dopa decarboxylase inhibitor treatment in Parkinson's disease."--Publisher's description